Literature DB >> 486970

Transient hypothyroidism after iodine-131 treatment for thyrotoxicosis.

I A MacFarlane, S M Shalet, C G Beardwell, J S Khara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 486970      PMCID： PMC1595610          DOI： 10.1136/bmj.2.6187.421

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Patients at risk of hypothyroidism.

Authors:  A D Toft; W J Irvine
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

2.  Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis.

Authors:  A D Toft; W J Irvine; J Seth; W M Hunter; E H Cameron
Journal:  Lancet       Date:  1975-09-27       Impact factor: 79.321

3.  Temporary hypothyroidism after surgical treatment of thyrotoxicosis.

Authors:  A D Toft; W J Irvine; D McIntosh; J Seth; E H Cameron; G P Lidgard
Journal:  Lancet       Date:  1976-10-16       Impact factor: 79.321
  3 in total
  5 in total

Review 1.  Subclinical hypothyroidism. To treat or not to treat.

Authors:  E A Laryea
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

2.  Low-dose 131I in treatment of Graves' disease.

Authors:  C P Lowdell; H J Dobbs; G S Spathis; V R McCready; D O Cosgrove; C L Harmer
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

3.  The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

Authors:  N R Peden; I R Hart
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

4.  Efficacy of Low-dose (2 millicurie) versus Standard-dose (4 millicurie) Radioiodine Treatment for Cats with Mild-to-Moderate Hyperthyroidism.

Authors:  J M Lucy; M E Peterson; J F Randolph; P V Scrivani; M Rishniw; D L Davignon; M S Thompson; J M Scarlett
Journal:  J Vet Intern Med       Date:  2017-02-03       Impact factor: 3.333

5.  Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.

Authors:  Anthony Lewis; Brew Atkinson; Patrick Bell; Hamish Courtney; David McCance; Karen Mullan; Stephen Hunter
Journal:  Ulster Med J       Date:  2013-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.